Effects of Early Clozapine Treatment on Remission Rates in Acute Schizophrenia (The EARLY Trial): Protocol of a Randomized-Controlled Multicentric Trial

Background Quick symptomatic remission after the onset of psychotic symptoms is critical in schizophrenia treatment, determining the subsequent disease course and recovery. In this context, only every second patient with acute schizophrenia achieves symptomatic remission within three months of initi...

Descripción completa

Detalles Bibliográficos
Autores principales: Wagner, Elias, Strube, Wolfgang, Görlitz, Thomas, Aksar, Aslihan, Bauer, Ingrid, Campana, Mattia, Moussiopoulou, Joanna, Hapfelmeier, Alexander, Wagner, Petra, Egert-Schwender, Silvia, Bittner, Robert, Eckstein, Kathrin, Nenadić, Igor, Kircher, Tilo, Langguth, Berthold, Meisenzahl, Eva, Lambert, Martin, Neff, Sigrid, Malchow, Berend, Falkai, Peter, Hirjak, Dusan, Böttcher, Kent-Tjorben, Meyer-Lindenberg, Andreas, Blankenstein, Christiane, Leucht, Stefan, Hasan, Alkomiet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2023
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484642/
https://www.ncbi.nlm.nih.gov/pubmed/37506738
http://dx.doi.org/10.1055/a-2110-4259

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10484642/
https://www.ncbi.nlm.nih.gov/pubmed/37506738
http://dx.doi.org/10.1055/a-2110-4259

Ejemplares similares